日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies

Sapanisertib (TAK-228) 在东亚晚期非血液系统恶性肿瘤患者中的 I 期研究

Shimizu, Toshio; Kuboki, Yasutoshi; Lin, Chia-Chi; Yonemori, Kan; Yanai, Tomoko; Faller, Douglas V; Dobler, Lwona; Gupta, Neeraj; Sedarati, Farhad; Kim, Kyu-Pyo

Correction to: A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies

更正:一项针对东亚晚期非血液系统恶性肿瘤患者的Sapanisertib (TAK-228) 1期研究

Shimizu, Toshio; Kuboki, Yasutoshi; Lin, Chia-Chi; Yonemori, Kan; Yanai, Tomoko; Faller, Douglas V; Dobler, Lwona; Gupta, Neeraj; Sedarati, Farhad; Kim, Kyu-Pyo

Safety, Tolerability, and Pharmacokinetics of TAK-931, a Cell Division Cycle 7 Inhibitor, in Patients with Advanced Solid Tumors: A Phase I First-in-Human Study

TAK-931(一种细胞周期蛋白7抑制剂)在晚期实体瘤患者中的安全性、耐受性和药代动力学:一项I期首次人体试验

Kuboki, Yasutoshi; Shimizu, Toshio; Yonemori, Kan; Kojima, Takashi; Kondo, Shunsuke; Koganemaru, Shigehiro; Iwasa, Satoru; Harano, Kenichi; Koyama, Takafumi; Lu, Vickie; Zhou, Xiaofei; Niu, Huifeng; Yanai, Tomoko; Garcia-Ribas, Ignacio; Doi, Toshihiko; Yamamoto, Noboru

SOCS3 deficiency in cardiomyocytes elevates sensitivity of ischemic preconditioning that synergistically ameliorates myocardial ischemia reperfusion injury

心肌细胞中 SOCS3 缺乏可提高缺血预处理的敏感性,从而协同改善心肌缺血再灌注损伤

Shoichiro Nohara, Mai Yamamoto, Hideo Yasukawa, Takanobu Nagata, Jinya Takahashi, Koutatsu Shimozono, Toshiyuki Yanai, Tomoko Sasaki, Kota Okabe, Tatsuhiro Shibata, Daiki Akagaki, Kazutoshi Mawatari, Yoshihiro Fukumoto

Interleukin-22 Directly Activates Myocardial STAT3 (Signal Transducer and Activator of Transcription-3) Signaling Pathway and Prevents Myocardial Ischemia Reperfusion Injury

白细胞介素-22直接激活心肌STAT3(信号转导和转录激活因子-3)信号通路,预防心肌缺血再灌注损伤

Jinya Takahashi,Mai Yamamoto,Hideo Yasukawa,Shoichiro Nohara,Takanobu Nagata,Koutatsu Shimozono,Toshiyuki Yanai,Tomoko Sasaki,Kota Okabe,Tatsuhiro Shibata,Kazutoshi Mawatari,Tatsuyuki Kakuma,Hiroki Aoki,Yoshihiro Fukumoto

Hematopoietic Stem Cell Transplantation and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large-Cell Lymphoma

造血干细胞移植联合维布妥昔单抗治疗复发或难治性霍奇金淋巴瘤和系统性间变性大细胞淋巴瘤

Ishizawa, Kenichi; Yanai, Tomoko

Differential expression of minimal residual disease markers in peripheral blood and bone marrow samples from high-risk neuroblastoma patients

高危神经母细胞瘤患者外周血和骨髓样本中微小残留病标志物的差异表达

Yamamoto, Nobuyuki; Kozaki, Aiko; Hartomo, Tri Budi; Yanai, Tomoko; Hasegawa, Daiichiro; Kawasaki, Keiichiro; Kosaka, Yoshiyuki; Matsuo, Masafumi; Hirase, Satoshi; Mori, Takeshi; Hayakawa, Akira; Iijima, Kazumoto; Nishio, Hisahide; Nishimura, Noriyuki

The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease.

首例青少年 TAFRO 综合征报告,这是一种独特的多中心 Castleman 病临床病理变异型

Kubokawa Ikuko, Yachie Akihiro, Hayakawa Akira, Hirase Satoshi, Yamamoto Nobuyuki, Mori Takeshi, Yanai Tomoko, Takeshima Yasuhiro, Kyo Eiryu, Kageyama Goichi, Nagai Hiroshi, Uehara Keiichiro, Kojima Masaru, Iijima Kazumoto

Primary pediatric endobronchial Ewing sarcoma family of tumors

原发性儿童支气管内尤文氏肉瘤家族肿瘤

Hayakawa, Akira; Hirase, Satoshi; Matsunoshita, Natsuki; Yamamoto, Nobuyuki; Kubokawa, Ikuko; Mori, Takeshi; Yanai, Tomoko; Maniwa, Yoshimasa; Iijima, Kazumoto

Epigallocatechin gallate inhibits sphere formation of neuroblastoma BE(2)-C cells.

表没食子儿茶素没食子酸酯抑制神经母细胞瘤BE(2)-C细胞的球体形成

Nishimura Noriyuki, Hartomo Tri Budi, Pham Thi Van Huyen, Lee Myeong Jin, Yamamoto Tomoto, Morikawa Satoru, Hasegawa Daiichiro, Takeda Hiroki, Kawasaki Keiichiro, Kosaka Yoshiyuki, Yamamoto Nobuyuki, Kubokawa Ikuko, Mori Takeshi, Yanai Tomoko, Hayakawa Akira, Takeshima Yasuhiro, Iijima Kazumoto, Matsuo Masafumi, Nishio Hisahide